Disclosure Of Fair Value Measurement [Text Block]

Medicover - Filing #5861825

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
2 138,2 EUR
1  941,3 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
1 648,9 EUR
1  413,0 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
735,000,000 EUR
4,180,000,000 EUR
307,000,000 EUR
245,000,000 EUR
243,000,000 EUR
7,000,000 EUR
4,648,000,000 EUR
651,000,000 EUR
1,000,000 EUR
328,000,000 EUR
4,893,000,000 EUR
5,283,000,000 EUR
1,285,000,000 EUR
1,098,000,000 EUR
318,000,000 EUR
4,585,000,000 EUR
307,000,000 EUR
356,000,000 EUR
8,000,000 EUR
4,965,000,000 EUR
3,000,000 EUR
247,000,000 EUR
5,085,000,000 EUR
963,000,000 EUR
361,000,000 EUR
4,586,000,000 EUR
208,000,000 EUR
1,249,000,000 EUR
6,000,000 EUR
304,000,000 EUR
667,000,000 EUR
4,724,000,000 EUR
13,000,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.